| Japan (N = 175) | Korea (N = 150) | Taiwan (N = 217) | Brazil (N = 175) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
EGFR/ALK tested | Not tested | EGFR/ALK tested | Not tested | EGFR/ALK tested | Not tested | EGFR/ALK tested | Not tested | |||||
Pos | Neg/Unk | Pos | Neg/Unk | Pos | Neg/Unk | Pos | Neg/Unk | |||||
First-line therapy | N = 49 | N = 81 | N = 45 | N = 53 | N = 59 | N = 38 | N = 126 | N = 59 | N = 32 | N = 13 | N = 61 | N = 101 |
No. inpatient staysa | 44 | 129 | 69 | 89 | 82 | 80 | 90 | 83 | 27 | 5 | 17 | 20 |
 Hospital | 44 (100) | 129 (100) | 69 (100) | 89 (100) | 82 (100) | 80 (100) | 90 (100) | 83 (100) | 27 (100) | 5 (100) | 17 (100) | 20 (100) |
No. hospitalizationsb | 44 | 131 | 69 | 89 | 82 | 80 | 90 | 83 | 29 | 5 | 19 | 20 |
 Normal ward | 44 (100) | 129 (99) | 69 (100) | 89 (100) | 82 (100) | 80 (100) | 90 (100) | 83 (100) | 27 (93) | 4 (80) | 17 (90) | 20 (100) |
 ICU | 0 | 2 (2) | 0 | 0 | 0 | 0 | 0 | 0 | 2 (7) | 1 (20) | 2 (11) | 0 |
No. hospitalizations with LOSc | 43 | 125 | 68 | 89 | 82 | 78 | 89 | 83 | 27 | 5 | 16 | 20 |
 Mean (SD) days | 25.3 (16.9) | 18.9 (15.4) | 15.5 (12.8) | 6.7 (7.4) | 7.7 (11.1) | 6.8 (9.9) | 12.9 (14.7) | 4.7 (3.3) | 8.6 (8.6) | 30.8 (24.2) | 17.8 (25.7) | 12.9 (14.8) |
 Median (range) | 21 (2–69) | 13 (1–81) | 13 (2–62) | 3 (1–39) | 3 (1–47) | 3 (1–45) | 7 (1–71) | 3 (1–17) | 5 (2–31) | 22 (4–68) | 6 (1–77) | 6 (2–55) |
Outpatient visits, nd | 34 | 58 | 33 | 75 | 80 | 41 | 81 | 44 | 24 | 8 | 41 | 49 |
 Mean (SD) visits | 17.5 (13.0) | 14.9 (23.7) | 16.5 (18.4) | 11.8 (11.0) | 14.2 (14.5) | 11.3 (6.9) | 16.3 (17.1) | 8.0 (7.0) | 17.0 (17.4) | 8.3 (7.5) | 9.5 (7.7) | 5.1 (5.9) |
 Median (range) | 15 (1–51) | 7 (1–124) | 8 (1–62) | 9 (1–51) | 9 (1–58) | 11 (1–27) | 12 (1–109) | 6 (1–27) | 12 (2–76) | 6 (2–22) | 8 (1–35) | 4 (1–36) |
No. outpatient visits | 595 | 863 | 546 | 882 | 1132 | 465 | 1321 | 352 | 407 | 66 | 389 | 251 |
Second-line therapy | N = 32 | N = 46 | N = 27 | N = 37 | N = 37 | N = 22 | N = 85 | N = 44 | N = 26 | N = 8 | N = 42 | N = 41 |
No. inpatient staysa | 26 | 27 | 24 | 29 | 18 | 32 | 120 | 28 | 13 | 1 | 11 | 10 |
 Hospital | 26 (100) | 27 (100) | 24 (100) | 29 (100) | 18 (100) | 31 (97) | 120 (100) | 28 (100) | 13 (100) | 1 (100) | 11 (100) | 10 (100) |
 Hospice | 0 | 0 | 0 | 0 | 0 | 1 (3) | 0 | 0 | 0 | 0 | 0 | 0 |
No. hospitalizationsb | 26 | 27 | 24 | 29 | 18 | 33 | 120 | 28 | 13 | 1 | 11 | 10 |
 Normal ward | 26 (100) | 27 (100) | 24 (100) | 29 (100) | 17 (94) | 31 (94) | 120 (100) | 28 (100) | 13 (100) | 1 (100) | 11 (100) | 10 (100) |
 ICU | 0 | 0 | 0 | 0 | 1 (6) | 2 (6) | 0 | 0 | 0 | 0 | 0 | 0 |
No. hospitalizations with LOSc | 26 | 27 | 23 | 29 | 18 | 31 | 120 | 28 | 13 | 1 | 11 | 10 |
 Mean (SD) days | 21.7 (15.0) | 21.5 (16.2) | 22.0 (16.4) | 8.7 (11.5) | 8.2 (7.1) | 5.9 (5.4) | 6.3 (7.4) | 12.5 (15.7) | 12.2 (10.5) | 5.0 (n/a) | 6.7 (5.3) | 11.8 (8.8) |
 Median (range) | 17 (3–63) | 17 (3–74) | 15 (4–54) | 4 (1–56) | 8 (1–26) | 2 (1–18) | 3 (1–52) | 6 (3–69) | 9 (3–37) | 5 | 6 (2–21) | 9 (2–30) |
Outpatient visits, nd | 18 | 26 | 19 | 48 | 41 | 18 | 45 | 27 | 18 | 2 | 22 | 18 |
 Mean (SD) visits | 6.8 (7.8) | 7.9 (6.6) | 16.1 (13.8) | 14.8 (14.0) | 8.6 (7.2) | 9.6 (13.2) | 11.7 (11.4) | 19.9 (23.6) | 17.8 (19.7) | 3.0 (0) | 5.7 (4.9) | 2.9 (2.0) |
 Median (range) | 3 (1–24) | 6 (1–26) | 14 (2–49) | 8 (1–49) | 5 (1–21) | 5 (1–45) | 9 (1–55) | 12 (1–92) | 12 (1–68) | 3 (3–3) | 5 (1–18) | 3 (1–6) |
No. outpatient visits | 122 | 205 | 305 | 710 | 351 | 172 | 525 | 537 | 320 | 6 | 126 | 53 |